doi: 10.1161/01.ATV.0000249623.79871.bc
© 2006 American Heart Association, Inc.
Editorials |
Origin of Neointimal Smooth Muscle
We’ve Come Full Circle
From the Department of Molecular Physiology and Biological Physics (M.H.H., J.A.T., G.K.O.) and the Department of Medicine, Cardiovascular Division (B.R.W.), University of Virginia, Charlottesville.
Correspondence to Dr Gary K. Owens, Department of Molecular Physiology and Biological Physics, University of Virginia, MR5 Room 1220, 415 Lane Road, PO Box 801394, Charlottesville, VA 22908. E-mail gko{at}virginia.edu
The origin of smooth muscle cells (SMCs) in atherosclerotic lesions has been a hotly debated topic for more than four decades. Until recently, it was widely accepted that the majority of smooth muscle cells in atherosclerotic lesions originate from the medial layer of the vessel wall, with local SMC proliferation and migration leading to remodeling of the vessel wall and vessel lumen.1,2 Recent reports in the literature, however, claimed that SMCs in atherosclerotic lesions originate primarily from circulating bone marrow progenitor cells.3,4 Where these cells originate from is not merely academic, because the cells that give rise to SMCs within atherosclerotic lesions would likely serve as targets for current and future therapeutic interventions. The bone marrow–derived origin suggested by these articles would indicate that attempts to control SMC phenotype in in-stent restenosis, transplant atherosclerosis, or fibrous cap rupture should be targeted toward these cells from the marrow. However, we cautioned in 2004 that if anything, the bone marrow–derived intimal SMC paradigm was "Lost in Transdifferentiation",5 and further studies were needed to clearly resolve this critically important issue.
See page 2696
In this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Bentzon and colleagues provide excellent evidence that bone marrow–derived cells do not give rise to vascular SMCs in hyperlipidemia-induced atherosclerotic plaques in the apoE knockout mouse.6 These investigators studied plaques in apoE–/– mice that had their bone marrow reconstituted from sex-mismatched apoE–/–/eGFP+ animals, and then performed meticulous high-resolution z-axis sectioning of atherosclerotic lesions induced by Western diet to try to identify transdifferentiated cells staining for both the eGFP/Y chromosome lineage tags and the SMC marker smooth muscle 
-actin (SMA). Of critical importance, and in contrast to many previous studies in this area where investigators examined relatively small numbers of intimal SMCs using low-resolution immunomicroscopy, Bentzon et al examined nearly 4000 lineage-traced cells in atherosclerotic lesions derived from these apoE–/– mice and based on extensive high-resolution z-axis sectioning found no colocalization of eGFP or sex-mismatched bone marrow–lineage markers and SMC markers, indicating no transdifferentiation of bone marrow derived cells into intimal SMCs. Moreover, using a sophisticated model of collar-induced lesion formation (that the authors assert more closely mimics human lesions) in transplanted syngeneic carotid arteries, they observed that SMCs within atherosclerotic lesions originated from the transplanted vessel. These results are completely consistent with a series of recent studies that have used high-resolution confocal analyses and shown little or no contribution of bone marrow–derived cells to SMC lineages in a variety of models including systemic hypoxia-induced arteriogenesis,7 hindlimb ischemia-induced angiogenesis/collateralization,8 regenerative lung growth,9 and tumor angiogenesis.8,10 Indeed, each of these articles showed that anything less than use of high-resolution confocal microscopy led to counting of false-positive transdifferentiation events. Results are also consistent with a more general study of this topic by Wagers et al11 indicating limited transdifferentiation of hematopoietic stem cells in any tissue using a parabiotic mouse model that lacks the confounding variables of irradiation and transplant. Finally, as described in detail our 2004 commentary on this topic,5 a fundamental flaw in virtually all previous studies claiming transdifferentiation of bone marrow–derived cells into SMCs was an over-reliance on use of the marker SMA, which we know can be expressed by many lineages other than SMCs.12 Whereas the absence of SMA as demonstrated by Bentzon et al provides compelling evidence ruling out SMC differentiation, the presence of this marker alone is not sufficient to establish SMC identity. Taken together, results provide what we believe is compelling evidence that so called transdifferentiation of bone marrow–derived cells into SMC lineages either does not occur at all or is a relatively rare event, at least in the models that have been rigorously studied to date.
In hindsight, the results of Bentzon et al should not have been too surprising because of the abundant literature from the 1970s and 1980s on proliferative and migratory responses of SMCs in various models of injury and hyperlipidemia. In particular, interested readers should seek out some of the seminal articles in the field that precisely demonstrated the nature of SMC proliferation and migration from the media in various animal models.13–19 Of these studies, two classic articles by Wilbur Thomas and colleagues in particular are difficult to reconcile with the bone marrow derivation of SMCs hypothesis in hyperlipidemic models of vascular disease. The first, an EM ultra-structural study of mitotic SMCs in atherosclerotic lesions, indicated mature SMCs dividing in the media were the source of proliferative SMCs.19 The second, a thymidine-lineage tracing study, demonstrated that medial SMC investing atherosclerotic lesions have a polyclonal origin.17 These findings seem to be inconsistent with a small or clonal stem-cell population dividing and differentiating within a lesion to form SMCs, and more congruous with proliferation and expansion of phenotypically modulated SMCs in the media of the vessel wall.
The controversy over the origin of SMCs within atherosclerotic lesions demonstrates the critical importance of using high-resolution confocal or deconvolution microscopy for any lineage tracing study, as well as rigorous statistical analysis of large numbers of individual cells in evaluating complex cell populations. It is somewhat regrettable, in hindsight, that progress in determining the origin of SMCs within atherosclerotic lesions was hindered by reports demonstrating the bone marrow origin of SMC without appropriate confocal microscopic analysis and/or study design of sufficient power. Indeed, the results of Bentzon and colleagues suggest a potential fundamental methodological flaw of previous studies demonstrating transdifferentiation of circulating stem cells into SMCs (Figure).
|
It should also be noted that hyperlipidemic models of atherosclerosis may be distinct from transplant atherosclerosis/arteriosclerosis (TA) models as well as injury-induced vascular lesion models. Based on several studies indicating a significant contribution of SMCs from marrow in these models, we believe a bone marrow or local stem cell origin of SMCs is possible in these situations,20–22 although these studies do suffer from the same lack of high-resolution 3D microscopic methods. Nevertheless, both severe vascular injury and TA are likely to elicit very different vascular responses than ordinary atherosclerosis or responses to systemic or local hypoxia. Indeed, the higher bone marrow contributions in TA may be related to multiple observations in the literature that host-versus-graft disease, a component of TA, results in medial necrosis, which may prime the media for progenitor cell investment and transdifferentiation. Similarly, there is evidence from Han et al showing that significant transdifferentiation of bone marrow cells into intimal SMC-like cells only occurred with severe but not modest injury.23 As such, the phenomenon of bone marrow transdifferentiation may be limited to models in which all or a significant fraction of medial SMCs have been eliminated either by mechanical damage or immune mechanisms. This being said, results of bone marrow lineage studies must be reconciled with the classic series of studies by Monika and Alexander Clowes, Stephen Schwartz, and colleagues in the 1980s that provided compelling evidence that severe injury of the rat carotid artery can elicit more than 50% of the medial SMC to enter the cell cycle, and that intimal lesion cells are derived from a combination of migration of medial SMC into the intima as well as proliferation of both medial and intimal SMCs.14,15
Bentzon et al with this report provide a definitive answer concerning the origin of SMCs in lesions within a mouse model of spontaneous atherosclerosis and in a sophisticated constrictive collar model, that will certainly have a large impact on the field. Yet, we must always be cautious in applying conclusions of these animal models to human disease. The quintessential experiment in humans that would prove or disprove the bone marrow origin of SMCs is, of course, not possible, because it would require confocal image analysis of the atherosclerotic lesions of several individuals whose bone marrow has been replaced with an autologous sample ex vivo engineered to express a lineage tracer. Alternatively, a careful analysis to determine whether bone marrow–derived cells contribute SMCs in lesions in humans could be done using pathologic samples from female recipients (X,X) of male donor (X,Y) bone marrow, similar to the excellent studies of Caplice et al,24 except using the higher resolution microscopic techniques and z-sectioning with confocal or deconvolution microscopy, similar to Bentzon et al, as well as more definitive markers for SMC lineage including smooth muscle myosin heavy chain,25–27 myocardin,28 LPP,29 and others,12 as well as markers for leukocytes to eliminate possible false-positives. However, even in this scenario, one must recognize that positive results may be attributable to the uncontrolled variables of bone marrow transplant/graft-versus-host disease, irradiation, chemotherapy, and use of immune-suppressant drugs in these patients, which may limit the relevance of such results to other more organic mechanisms of lesion formation in humans.
Herein, Bentzon et al definitively demonstrate that SMCs in lesions within a mouse model of spontaneous atherosclerosis originate entirely from the local blood vessel wall. This article exemplifies excellent, thorough analyses, the use of high-resolution techniques, and the need, when major scientific paradigms are overturned, to demand better explanations for how new theories incorporate previous valid data and amplify our understanding of the older literature. Their study illuminates the methodological deficiencies that suggested bone marrow origins of intimal SMC in vivo; their data are consistent with the well-established literature in the field, and as a result, their study has brought us full circle in our understanding of origins of SMC in vascular pathologies.
 |
Acknowledgments |
|---|
Disclosures
None.
|
References |
|---|
 Top References |
|---|
1. Ross R. Atherosclerosis: an Inflammatory Disease. N Engl J Med. 1999; 340: 115–126.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362: 801–809.[CrossRef][Medline] [Order article via Infotrieve]
3. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med. 2001; 7: 382–383.[CrossRef][Medline] [Order article via Infotrieve]
4. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002; 8: 403–409.[CrossRef][Medline] [Order article via Infotrieve]
5. Hoofnagle MH, Wamhoff BR, Owens GK. Lost in transdifferentiation. J Clin Invest. 2004; 113: 1249–1251.[CrossRef][Medline] [Order article via Infotrieve]
6. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in apoE knockout mice. Arterioscler Thromb Vasc Biol. 2006; 26: 2696–2702.[CrossRef][Medline] [Order article via Infotrieve]
7. O’Neill TJ, IV, Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res. 2005; 97: 1027–1035.
8. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, Schaper W. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res. 2004; 94: 230–238.
9. Voswinckel R, Ziegelhoeffer T, Heil M, Kostin S, Breier G, Mehling T, Haberberger R, Clauss M, Gaumann A, Schaper W, Seeger W. Circulating vascular progenitor cells do not contribute to compensatory lung growth. Circ Res. 2003; 93: 372–379.
10. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med. 2003; 9: 789–795.[CrossRef][Medline] [Order article via Infotrieve]
11. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002; 297: 2256–2259.
12. Owens GK, Kumar MS, Wamhoff BR. Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease. Physiol Rev. 2004; 84: 767–801.
13. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983; 49: 208–215.[Medline] [Order article via Infotrieve]
14. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 1983; 49: 327–333.[Medline] [Order article via Infotrieve]
15. Schwartz SM, Stemerman MB, Benditt EP. The aortic intima. II. Repair of the aortic lining after mechanical denudation. Am J Pathol. 1975; 81: 15–42.[Abstract]
16. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest. 1986; 54: 295–303.[Medline] [Order article via Infotrieve]
17. Thomas WA, Florentin RA, Reiner JM, Lee WM, Lee KT. Alterations in population dynamics of arterial smooth muscle cells during atherogenesis : IV. Evidence for a polyclonal origin of hypercholesterolemic diet-induced atherosclerotic lesions in young swine. Exper Mol Pathol. 1976; 24: 244–260.[CrossRef]
18. Clowes AW, Clowes MM, Fingerle JF, Reidy MA. Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. Lab Invest. 1989; 60: 360–364.[Medline] [Order article via Infotrieve]
19. Imai HF, Lee KJ, Lee SK, Lee KT, O’Neal RM, Thomas WA. Ultrastructural features of aortic cells in mitosis in control and cholesterol-fed swine. Lab Invest. 1970; 23: 401–415.[Medline] [Order article via Infotrieve]
20. Glaser R, Lu MM, Narula N, Epstein JA. Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human Hearts. Circulation. 2002; 106: 17–19.
21. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Chimerism of the Transplanted Heart. N Engl J Med. 2002; 346: 5–15.
22. Hu Y, Davison F, Ludewig B, Erdel M, Mayr M, Url M, Dietrich H, Xu Q. Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor Cells. Circulation. 2002; 106: 1834–1839.
23. Han CL, Campbell GR, Campbell JH. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res. 2001; 38: 113–119.[CrossRef][Medline] [Order article via Infotrieve]
24. Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A. 2003; 0730743100.
25. Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S, Ueda M, Yamaguchi H, Yazaki Y, Periasamy M. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res. 1993; 73: 1000–1012.
26. Babij P, Kelly C, Periasamy M. Characterization of a Mammalian Smooth Muscle Myosin Heavy-Chain Gene: Complete Nucleotide and Protein Coding Sequence and Analysis of the 5' End of the Gene. Proc Natl Acad Sci U S A. 1991; 88: 10676–10680.
27. Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res. 1994; 75: 803–812.
28. Wang DZ, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN. Activation of Cardiac Gene Expression by Myocardin, a Transcriptional Cofactor for Serum Response Factor. Cell. 2001; 105: 851–862.[CrossRef][Medline] [Order article via Infotrieve]
29. Gorenne I, Jin L, Yoshida T, Sanders JM, Sarembock IJ, Owens GK, Somlyo AP, Somlyo AV. LPP Expression During In Vitro Smooth Muscle Differentiation and Stent-Induced Vascular Injury. Circ Res. 2006; 98: 378–385.
Related Article:
Arterioscler Thromb Vasc Biol 2006 26: 2696-2702.
This article has been cited by other articles:
 |
|
 |
|
  D. Morrow, J. P. Cullen, W. Liu, S. Guha, C. Sweeney, Y. A. Birney, N. Collins, D. Walls, E. M. Redmond, and P. A. Cahill Sonic Hedgehog Induces Notch Target Gene Expression in Vascular Smooth Muscle Cells via VEGF-A Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1112 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Monahan, N. D. Andersen, M. C. Martin, J. Y. Malek, G. V. Shrikhande, L. Pradhan, C. Ferran, and F. W. LoGerfo MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein FASEB J, February 1, 2009; 23(2): 557 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jin, T. Yoshida, R. Ho, G. K. Owens, and A. V. Somlyo The Actin-associated Protein Palladin Is Required for Development of Normal Contractile Properties of Smooth Muscle Cells Derived from Embryoid Bodies J. Biol. Chem., January 23, 2009; 284(4): 2121 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Iwata and M. Sata Origin of Cells That Contribute to Neointima Growth Circulation, June 17, 2008; 117(24): 3060 - 3061. [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Xu Stem Cells and Transplant Arteriosclerosis Circ. Res., May 9, 2008; 102(9): 1011 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Diao, S. Guthrie, S.-L. Xia, X. Ouyang, L. Zhang, J. Xue, P. Lee, M. Grant, E. Scott, and M. S. Segal Long-Term Engraftment of Bone Marrow-Derived Cells in the Intimal Hyperplasia Lesion of Autologous Vein Grafts Am. J. Pathol., March 1, 2008; 172(3): 839 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Schneider, G. K. Sukhova, M. Aikawa, J. Canner, N. Gerdes, S.-M. T. Tang, G.-P. Shi, S. S. Apte, and P. Libby Matrix Metalloproteinase-14 Deficiency in Bone Marrow-Derived Cells Promotes Collagen Accumulation in Mouse Atherosclerotic Plaques Circulation, February 19, 2008; 117(7): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tanaka, M. Sata, T. Natori, J.-r. Kim-Kaneyama, K. Nose, M. Shibanuma, Y. Hirata, and R. Nagai Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice FASEB J, February 1, 2008; 22(2): 428 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Zhang, S. Zhuang, D. E. Casteel, D. J. Looney, G. R. Boss, and R. B. Pilz A Cysteine-rich LIM-only Protein Mediates Regulation of Smooth Muscle-specific Gene Expression by cGMP-dependent Protein Kinase J. Biol. Chem., November 16, 2007; 282(46): 33367 - 33380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shimizu, T. Nakazawa, A. Cho, F. Dastvan, D. Shilling, G. Daum, and M. A. Reidy Sphingosine 1-Phosphate Receptor 2 Negatively Regulates Neointimal Formation in Mouse Arteries Circ. Res., November 9, 2007; 101(10): 995 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Bentzon, C. S. Sondergaard, M. Kassem, and E. Falk Smooth Muscle Cells Healing Atherosclerotic Plaque Disruptions Are of Local, Not Blood, Origin in Apolipoprotein E Knockout Mice Circulation, October 30, 2007; 116(18): 2053 - 2061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Grainger TGF-{beta} and atherosclerosis in man Cardiovasc Res, May 1, 2007; 74(2): 213 - 222. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||